当前位置: 首页 SCI期刊 SCIE期刊 JCRQ4 期刊介绍(非官网)
Journal Of Cancer Metastasis And Treatment

Journal Of Cancer Metastasis And TreatmentSCIE

国际简称:J CANCER METAS TREAT  参考译名:癌症转移与治疗杂志

  • CiteScore分区

    Q3

  • JCR分区

    Q4

基本信息:
ISSN:2394-4722
E-ISSN:2454-2857
是否OA:未开放
是否预警:否
出版信息:
出版商:OAE Publishing Inc.
出版语言:English
研究方向:ONCOLOGY
评价信息:
影响因子:1.4
CiteScore指数:3.2
SJR指数:0.49
SNIP指数:0.43
发文数据:
Gold OA文章占比:98.71%
研究类文章占比:33.33%
年发文量:42
英文简介 期刊介绍 CiteScore数据 JCR分区 常见问题

英文简介Journal Of Cancer Metastasis And Treatment期刊介绍

The Journal of Cancer Metastasis and Treatment is an internationally peer-reviewed journal dedicated to research on cancer metastasis and treatment. The journal aims to publish original research articles on cancer biology, molecular mechanisms, clinical treatment strategies, drug development, as well as cancer prevention and screening. The journal covers a wide range of research fields from basic science to translational medicine, aiming to provide a platform for cancer researchers, clinical doctors, and related health professionals to exchange the latest research results.

The journal emphasizes interdisciplinary research and encourages submissions of research involving fields such as molecular biology, genetics, immunology, pharmacology, epidemiology, and biostatistics. By publishing high-quality research papers, the magazine is committed to promoting scientific progress in the field of cancer treatment, improving the prognosis of patients, and ultimately reducing the incidence rate and mortality of cancer. The editorial team of the journal is composed of internationally renowned cancer research experts, who ensure the scientific rigor and innovation of the published articles. In addition, the journal ensures that all published research meets international academic standards through a rigorous peer review process.

期刊简介Journal Of Cancer Metastasis And Treatment期刊介绍

《Journal Of Cancer Metastasis And Treatment》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间:
  • SCIE
  • 非预警

Cite Score数据(2024年最新版)Journal Of Cancer Metastasis And Treatment Cite Score数据

  • CiteScore:3.2
  • SJR:0.485
  • SNIP:0.427
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q3 240 / 404

40%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Journal Of Cancer Metastasis And Treatment JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 263 / 322

18.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 287 / 322

11.02%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题